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Background:  Patients with end stage renal disease (ESRD) have a cardiovascular mortality about 15-30 times the general population. 
Dobutamine stress echocardiography (DSE) is commonly performed in their preoperative cardiac evaluation before renal transplantation. 
Hypertensive response during DSE defined as stress induced systolic blood pressure >220 mmHg or diastolic blood pressure of >110 mmHg occurs 
in about 1% of DSE studies. This phenomenon seems to be more frequent in patients with renal failure patients, but its precise frequency and 
clinical implications in ESRD population is not known.
Methods:  Of the 250 consecutive adult ESRD patients undergoing DSE for pre-kidney transplant cardiac risk assessment at our clinic 53 (22%) 
had a hypertensive response. Its clinical correlates and implications were analyzed.
Results:  Base line characteristics ( n= 250) were: age 57+ 11 years, female 47%, hypertension 96%, diabetes 72% , 82 % on hemodialysis. 
The predictors of hypertensive response were higher baseline systolic (p< 0.0001) and diastolic (p= 0.04) blood pressures, LV hypertrophy on 
echocardiography (p=0.01), treatment with angiotensin converting enzyme inhibitors (p=0.004) and marginally number of antihypertensive agents 
(p=0.08). Of the 53 (22%) with a hypertensive response, 25 (47%) had stress induced segmental wall motion abnormalities (SWMA). Of the 25 
patients with SWMA, 22 had a coronary angiogram and of them 45% had significant coronary artery disease. The hypertensive response was a strong 
predictor of SWMA (RR 2.8, p=0.002), but was not predictor of significant CAD (RR 1.1, P=0.81). Neither the hypertensive response nor a true or 
false positive stress was predictive of mortality over a period of 22 months.
Conclusions:  1) ESRD patients have high prevalence of hypertensive response to dobutamine stress (22%) and this is predicted by basal 
blood pressure levels, LV hypertrophy and the need for larger number of antihypertensive medications. 2) Stress induced SWMA associated with 
a hypertensive response is a poor predictor of significant coronary artery disease (55% false positive rate) and is not associated with increased 
mortality.
